Details of the change in the Cigna Group Medical Plan were announced in an email to employees on Monday
Determining whether these regimes are mechanistically distinct or simply represent different scales of the same propagative process remains an important challenge for future investigation
If your weight loss stalls on Semaglutide (Ozempic), your doctor may switch you to Tirzepatide (Zepbound/Mounjaro) , which targets two hunger hormones instead of one and often yields higher total weight loss percentages
switch to a hydrophilic statin (rosuvastatin, pravastatin) if myalgias localize SGLT2 inhibitors: reinforce hydration targets (minimum 2.5 L daily) Laxatives or stimulant bowel preps: reduce frequency if already experiencing GLP-1-related diarrhea Tier 3: Low risk but worth documenting ACE inhibitors (can rarely cause cramps through unclear mechanisms) Beta-agonist inhalers (albuterol can lower serum potassium at high doses) The Endocrine Society's 2023 clinical practice guideline on pharmacologic management of obesity recommends monitoring electrolytes during the titration phase of anti-obesity medications, with particular attention to patients on concurrent diuretic therapy 9
So maybe I didn't get everything I wanted, but I always got what I needed in order to progress
in: PubMed | Google Scholar Authorship note: MS and MMH contributed equally to this work
